TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Siegel, R. AU - DeSantis, C. AU - Jemal, A. PY - 2014 DA - 2014// TI - Colorectal cancer statistics, 2014 JO - CA Cancer J Clin VL - 64 UR - https://doi.org/10.3322/caac.21220 DO - 10.3322/caac.21220 ID - Siegel2014 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. AU - Zhang, S. AU - Zeng, H. AU - Bray, F. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Field, K. AU - Lipton, L. PY - 2007 DA - 2007// TI - Metastatic colorectal cancer-past, progress and future JO - World J Gastroenterol VL - 13 UR - https://doi.org/10.3748/wjg.v13.i28.3806 DO - 10.3748/wjg.v13.i28.3806 ID - Field2007 ER - TY - JOUR AU - Nordlinger, B. AU - Cutsem, E. AU - Gruenberger, T. AU - Glimelius, B. AU - Poston, G. AU - Rougier, P. PY - 2009 DA - 2009// TI - Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn735 DO - 10.1093/annonc/mdn735 ID - Nordlinger2009 ER - TY - JOUR AU - Manfredi, S. AU - Bouvier, A. M. AU - Lepage, C. AU - Hatem, C. AU - Dancourt, V. AU - Faivre, J. PY - 2006 DA - 2006// TI - Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population JO - Br J Surg VL - 93 UR - https://doi.org/10.1002/bjs.5349 DO - 10.1002/bjs.5349 ID - Manfredi2006 ER - TY - JOUR AU - Smith, M. D. AU - McCall, J. L. PY - 2009 DA - 2009// TI - Systematic review of tumour number and outcome after radical treatment of colorectal liver metastases JO - Br J Surg VL - 96 UR - https://doi.org/10.1002/bjs.6735 DO - 10.1002/bjs.6735 ID - Smith2009 ER - TY - JOUR AU - Zetter, B. R. PY - 1998 DA - 1998// TI - Angiogenesis and tumor metastasis JO - Annu Rev Med VL - 49 UR - https://doi.org/10.1146/annurev.med.49.1.407 DO - 10.1146/annurev.med.49.1.407 ID - Zetter1998 ER - TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Angiogenesis in cancer, vascular, rheumatoid and other disease JO - Nat Med VL - 1 UR - https://doi.org/10.1038/nm0195-27 DO - 10.1038/nm0195-27 ID - Folkman1995 ER - TY - JOUR AU - Ferrara, N. AU - Kerbel, R. S. PY - 2005 DA - 2005// TI - Angiogenesis as a therapeutic target JO - Nature VL - 438 UR - https://doi.org/10.1038/nature04483 DO - 10.1038/nature04483 ID - Ferrara2005 ER - TY - JOUR AU - Ferrara, N. AU - Gerber, H. P. AU - LeCouter, J. PY - 2003 DA - 2003// TI - The biology of VEGF and its receptors JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm0603-669 DO - 10.1038/nm0603-669 ID - Ferrara2003 ER - TY - JOUR AU - Cheng, Y. D. AU - Yang, H. AU - Chen, G. Q. AU - Zhang, Z. C. PY - 2013 DA - 2013// TI - Molecularly targeted drugs for metastatic colorectal cancer JO - Drug Des Devel Ther VL - 7 ID - Cheng2013 ER - TY - JOUR AU - Hurwitz, H. AU - Fehrenbacher, L. AU - Novotny, W. AU - Cartwright, T. AU - Hainsworth, J. AU - Heim, W. PY - 2004 DA - 2004// TI - Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa032691 DO - 10.1056/NEJMoa032691 ID - Hurwitz2004 ER - TY - JOUR AU - Falchook, G. S. AU - Kurzrock, R. PY - 2015 DA - 2015// TI - VEGF and dual-EGFR inhibition in colorectal cancer JO - Cell Cycle VL - 14 UR - https://doi.org/10.1080/15384101.2015.1022071 DO - 10.1080/15384101.2015.1022071 ID - Falchook2015 ER - TY - JOUR AU - Gschwind, A. AU - Fischer, O. M. AU - Ullrich, A. PY - 2004 DA - 2004// TI - The discovery of receptor tyrosine kinases: targets for cancer therapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1360 DO - 10.1038/nrc1360 ID - Gschwind2004 ER - TY - JOUR AU - Dahabreh, I. J. AU - Terasawa, T. AU - Castaldi, P. J. AU - Trikalinos, T. A. PY - 2011 DA - 2011// TI - Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer JO - Ann Intern Med VL - 154 UR - https://doi.org/10.7326/0003-4819-154-1-201101040-00006 DO - 10.7326/0003-4819-154-1-201101040-00006 ID - Dahabreh2011 ER - TY - JOUR AU - Lichtenberger, B. M. AU - Tan, P. K. AU - Niederleithner, H. AU - Ferrara, N. AU - Petzelbauer, P. AU - Sibilia, M. PY - 2010 DA - 2010// TI - Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development JO - Cell VL - 140 UR - https://doi.org/10.1016/j.cell.2009.12.046 DO - 10.1016/j.cell.2009.12.046 ID - Lichtenberger2010 ER - TY - JOUR AU - Tortora, G. AU - Ciardiello, F. AU - Gasparini, G. PY - 2008 DA - 2008// TI - Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications JO - Nat Clin Pract Oncol VL - 5 UR - https://doi.org/10.1038/ncponc1161 DO - 10.1038/ncponc1161 ID - Tortora2008 ER - TY - JOUR AU - Ding, C. AU - Luo, J. AU - Yu, W. AU - Gao, S. AU - Yang, L. AU - Chen, C. PY - 2015 DA - 2015// TI - Gab2 is a novel prognostic factor for colorectal cancer patients JO - Int J Clin Exp Pathol VL - 8 ID - Ding2015 ER - TY - JOUR AU - Ding, C. AU - Luo, J. AU - Li, L. AU - Li, S. AU - Yang, L. AU - Pan, H. PY - 2016 DA - 2016// TI - Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-015-0280-0 DO - 10.1186/s13046-015-0280-0 ID - Ding2016 ER - TY - JOUR AU - Naito, S. AU - Eschenbach, A. C. AU - Giavazzi, R. AU - Fidler, I. J. PY - 1986 DA - 1986// TI - Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice JO - Cancer Res VL - 46 ID - Naito1986 ER - TY - JOUR AU - Weidner, N. AU - Semple, J. P. AU - Welch, W. R. AU - Folkman, J. PY - 1991 DA - 1991// TI - Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma JO - N Engl J Med VL - 324 UR - https://doi.org/10.1056/NEJM199101033240101 DO - 10.1056/NEJM199101033240101 ID - Weidner1991 ER - TY - JOUR AU - Giordano, G. AU - Febbraro, A. AU - Tomaselli, E. AU - Sarnicola, M. L. AU - Parcesepe, P. AU - Parente, D. PY - 2015 DA - 2015// TI - Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0225-7 DO - 10.1186/s13046-015-0225-7 ID - Giordano2015 ER - TY - JOUR AU - Thomaidis, T. AU - Maderer, A. AU - Formentini, A. AU - Bauer, S. AU - Trautmann, M. AU - Schwarz, M. PY - 2014 DA - 2014// TI - Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial JO - J Exp Clin Cancer Res VL - 33 UR - https://doi.org/10.1186/s13046-014-0083-8 DO - 10.1186/s13046-014-0083-8 ID - Thomaidis2014 ER - TY - JOUR AU - Wang, T. AU - Liu, J. AU - Xiao, X. Q. PY - 2015 DA - 2015// TI - Cantharidin inhibits angiogenesis by suppressing VEGF-induced JAK1/STAT3, ERK and AKT signaling pathways JO - Arch Pharm Res VL - 38 UR - https://doi.org/10.1007/s12272-014-0383-8 DO - 10.1007/s12272-014-0383-8 ID - Wang2015 ER - TY - JOUR AU - Ding, C. B. AU - Yu, W. N. AU - Feng, J. H. AU - Luo, J. M. PY - 2015 DA - 2015// TI - Structure and function of Gab2 and its role in cancer (Review) JO - Mol Med Rep VL - 12 ID - Ding2015 ER - TY - JOUR AU - Iliopoulos, D. AU - Hirsch, H. A. AU - Struhl, K. PY - 2009 DA - 2009// TI - An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation JO - Cell VL - 139 UR - https://doi.org/10.1016/j.cell.2009.10.014 DO - 10.1016/j.cell.2009.10.014 ID - Iliopoulos2009 ER - TY - JOUR AU - Huang, H. AU - Weng, H. AU - Zhou, H. AU - Qu, L. PY - 2014 DA - 2014// TI - Attacking c-Myc: targeted and combined therapies for cancer JO - Curr Pharm Des VL - 20 UR - https://doi.org/10.2174/1381612820666140826153203 DO - 10.2174/1381612820666140826153203 ID - Huang2014 ER - TY - JOUR AU - Cortés Sempere, M. AU - Rodríguez Fanjul, V. AU - Sánchez Pérez, I. AU - Perona, R. PY - 2008 DA - 2008// TI - The role of the NFkappaB signaling pathway in cancer JO - Clin Transl Oncol VL - 10 UR - https://doi.org/10.1007/s12094-008-0171-3 DO - 10.1007/s12094-008-0171-3 ID - Cortés Sempere2008 ER - TY - JOUR AU - Ghosh, S. AU - Karin, M. PY - 2002 DA - 2002// TI - Missing pieces in the NF-kappaB puzzle JO - Cell VL - 109 UR - https://doi.org/10.1016/S0092-8674(02)00703-1 DO - 10.1016/S0092-8674(02)00703-1 ID - Ghosh2002 ER - TY - JOUR AU - Zhang, N. N. AU - Sun, Q. S. AU - Chen, Z. AU - Liu, F. AU - Jiang, Y. Y. PY - 2013 DA - 2013// TI - Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells JO - Mol Cell Biochem VL - 372 UR - https://doi.org/10.1007/s11010-012-1445-1 DO - 10.1007/s11010-012-1445-1 ID - Zhang2013 ER - TY - JOUR AU - Zafirellis, K. AU - Agrogiannis, G. AU - Zachaki, A. AU - Gravani, K. AU - Karameris, A. AU - Kombouras, C. PY - 2008 DA - 2008// TI - Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer JO - J Surg Res VL - 147 UR - https://doi.org/10.1016/j.jss.2007.05.041 DO - 10.1016/j.jss.2007.05.041 ID - Zafirellis2008 ER - TY - JOUR AU - Mokhtari, M. AU - Ardestani, M. M. AU - Movahedipour, M. PY - 2012 DA - 2012// TI - An immunohistochemical study of EGFR expression in colorectal cancer and its correlation with lymph nodes status and tumor grade JO - J Res Med Sci VL - 17 ID - Mokhtari2012 ER - TY - JOUR AU - Simone, G. AU - Mangia, A. AU - Malfettone, A. AU - Rubini, V. AU - Siciliano, M. AU - Benedetto, A. PY - 2010 DA - 2010// TI - Chromogenic in situ hybridization to detect EGFR gene copy number in cell blocks from fine-needle aspirates of non small cell lung carcinomas and lung metastases from colo-rectal cancer JO - J Exp Clin Cancer Res VL - 29 UR - https://doi.org/10.1186/1756-9966-29-125 DO - 10.1186/1756-9966-29-125 ID - Simone2010 ER - TY - JOUR AU - Komatsu, Y. AU - Ishioka, C. AU - Shimada, K. AU - Yamada, Y. AU - Gamoh, M. AU - Sato, A. PY - 2015 DA - 2015// TI - Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1630-1 DO - 10.1186/s12885-015-1630-1 ID - Komatsu2015 ER - TY - JOUR AU - Liu, X. AU - George, G. C. AU - Tsimberidou, A. M. AU - Naing, A. AU - Wheler, J. J. AU - Kopetz, S. PY - 2015 DA - 2015// TI - Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1701-3 DO - 10.1186/s12885-015-1701-3 ID - Liu2015 ER - TY - JOUR AU - Kim, K. J. AU - Li, B. AU - Winer, J. AU - Armanini, M. AU - Gillett, N. AU - Phillips, H. S. PY - 1993 DA - 1993// TI - Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo JO - Nature VL - 362 UR - https://doi.org/10.1038/362841a0 DO - 10.1038/362841a0 ID - Kim1993 ER - TY - JOUR AU - Asano, M. AU - Yukita, A. AU - Suzuki, H. PY - 1999 DA - 1999// TI - Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor JO - Jpn J Cancer Res VL - 90 UR - https://doi.org/10.1111/j.1349-7006.1999.tb00671.x DO - 10.1111/j.1349-7006.1999.tb00671.x ID - Asano1999 ER - TY - JOUR AU - Carrato, A. AU - Gallego-Plazas, J. AU - Guillen-Ponce, C. PY - 2006 DA - 2006// TI - Anti-VEGF therapy: a new approach to colorectal cancer therapy JO - Expert Rev Anticancer Ther VL - 6 UR - https://doi.org/10.1586/14737140.6.10.1385 DO - 10.1586/14737140.6.10.1385 ID - Carrato2006 ER - TY - JOUR AU - Papadimitriou, K. AU - Rolfo, C. AU - Dewaele, E. AU - Wiel, M. AU - Brande, J. AU - Altintas, S. PY - 2015 DA - 2015// TI - Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer JO - Curr Treat Options Oncol VL - 16 UR - https://doi.org/10.1007/s11864-015-0333-9 DO - 10.1007/s11864-015-0333-9 ID - Papadimitriou2015 ER - TY - STD TI - Zaniboni A, Formica V. The Best. First. Anti-EGFR before anti-VEGF, in the first-line treatment of RAS wild-type metastatic colorectal cancer: from bench to bedside. Cancer Chemother Pharmacol. 2016. ID - ref41 ER - TY - JOUR AU - Shaheen, R. M. AU - Ahmad, S. A. AU - Liu, W. AU - Reinmuth, N. AU - Jung, Y. D. AU - Tseng, W. W. PY - 2001 DA - 2001// TI - Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors JO - Br J Cancer VL - 85 UR - https://doi.org/10.1054/bjoc.2001.1936 DO - 10.1054/bjoc.2001.1936 ID - Shaheen2001 ER - TY - JOUR AU - Ellis, L. M. PY - 2004 DA - 2004// TI - Epidermal growth factor receptor in tumor angiogenesis JO - Hematol Oncol Clin North Am VL - 18 UR - https://doi.org/10.1016/j.hoc.2004.06.002 DO - 10.1016/j.hoc.2004.06.002 ID - Ellis2004 ER - TY - JOUR AU - Tabernero, J. PY - 2007 DA - 2007// TI - The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents JO - Mol Cancer Res VL - 5 UR - https://doi.org/10.1158/1541-7786.MCR-06-0404 DO - 10.1158/1541-7786.MCR-06-0404 ID - Tabernero2007 ER - TY - JOUR AU - Ye, Q. AU - Cai, W. AU - Zheng, Y. AU - Evers, B. M. AU - She, Q. B. PY - 2014 DA - 2014// TI - ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer JO - Oncogene VL - 33 UR - https://doi.org/10.1038/onc.2013.122 DO - 10.1038/onc.2013.122 ID - Ye2014 ER - TY - JOUR AU - Troiani, T. AU - Napolitano, S. AU - Vitagliano, D. AU - Morgillo, F. AU - Capasso, A. AU - Sforza, V. PY - 2014 DA - 2014// TI - Primary and acquired resistance of colorectal cancer cells to anti-EGFR antibodies converge on MEK/ERK pathway activation and can be overcome by combined MEK/EGFR inhibition JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2181 DO - 10.1158/1078-0432.CCR-13-2181 ID - Troiani2014 ER - TY - JOUR AU - Papadatos-Pastos, D. AU - Rabbie, R. AU - Ross, P. AU - Sarker, D. PY - 2015 DA - 2015// TI - The role of the PI3K pathway in colorectal cancer JO - Crit Rev Oncol Hematol VL - 94 UR - https://doi.org/10.1016/j.critrevonc.2014.12.006 DO - 10.1016/j.critrevonc.2014.12.006 ID - Papadatos-Pastos2015 ER - TY - JOUR AU - Wu, J. AU - Zhang, J. AU - Shen, B. AU - Yin, K. AU - Xu, J. AU - Gao, W. PY - 2015 DA - 2015// TI - Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0229-3 DO - 10.1186/s13046-015-0229-3 ID - Wu2015 ER - TY - JOUR AU - Qin, A. AU - Yu, Q. AU - Gao, Y. AU - Tan, J. AU - Huang, H. AU - Qiao, Z. PY - 2015 DA - 2015// TI - Inhibition of STAT3/cyclinD1 pathway promotes chemotherapeutic sensitivity of colorectal caner JO - Biochem Biophys Res Commun VL - 457 UR - https://doi.org/10.1016/j.bbrc.2015.01.048 DO - 10.1016/j.bbrc.2015.01.048 ID - Qin2015 ER - TY - JOUR AU - Wang, S. W. AU - Sun, Y. M. PY - 2014 DA - 2014// TI - The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review) JO - Int J Oncol VL - 44 ID - Wang2014 ER - TY - JOUR AU - Tan, J. AU - Yu, Q. PY - 2013 DA - 2013// TI - Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy JO - Chin J Cancer VL - 32 UR - https://doi.org/10.5732/cjc.012.10287 DO - 10.5732/cjc.012.10287 ID - Tan2013 ER - TY - JOUR AU - Li, J. AU - Xiang, S. AU - Zhang, Q. AU - Wu, J. AU - Tang, Q. AU - Zhou, J. PY - 2015 DA - 2015// TI - Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C JO - J Exp Clin Cancer Res VL - 34 UR - https://doi.org/10.1186/s13046-015-0168-z DO - 10.1186/s13046-015-0168-z ID - Li2015 ER - TY - JOUR AU - Turkson, J. PY - 2004 DA - 2004// TI - STAT proteins as novel targets for cancer drug discovery JO - Expert Opin Ther Targets VL - 8 UR - https://doi.org/10.1517/14728222.8.5.409 DO - 10.1517/14728222.8.5.409 ID - Turkson2004 ER - TY - JOUR AU - Chaturvedi, M. M. AU - Sung, B. AU - Yadav, V. R. AU - Kannappan, R. AU - Aggarwal, B. B. PY - 2011 DA - 2011// TI - NF-κB addiction and its role in cancer: ‘one size does not fit all’ JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.566 DO - 10.1038/onc.2010.566 ID - Chaturvedi2011 ER - TY - JOUR AU - García-Alfonso, P. AU - Grande, E. AU - Polo, E. AU - Afonso, R. AU - Reina, J. J. AU - Jorge, M. PY - 2014 DA - 2014// TI - The role of antiangiogenic agents in the treatment of patients with advanced colorectal cancer according to K-RAS status JO - Angiogenesis VL - 17 UR - https://doi.org/10.1007/s10456-014-9433-6 DO - 10.1007/s10456-014-9433-6 ID - García-Alfonso2014 ER - TY - STD TI - Li X, Wang M, Liu GY, Ma JL. Dual VEGF/EGFR inhibition versus single targeted agent treatment in patients with metastatic colorectal cancer: a meta-analysis of randomized trials. Int J Colorectal Dis. 2016;31:1655-6. ID - ref56 ER -